THE UNIVERSITY OF BRITISH COLUMBIA;GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
BARROS AGUIRRE, DAVID,BATES, ROBERT H.,GONZALEZ DEL RIO, RUBEN,MENDOZA LOSANA, ALFONSO,RAMON, GARCIA SANTIAGO
申请号：
CA3060396
公开号：
CA3060396A1
申请日:
2018.05.04
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present invention relates to formula (I) or a pharmaceuticallyacceptable salt or ester prodrug thereof for use in the treatment of amycobacterialinfection or disease resulting from a mycobacterial infection, such astuberculosis.
